Szecówka J, Tendler D, Efendić S
Am J Physiol. 1983 Oct;245(4):E313-7. doi: 10.1152/ajpendo.1983.245.4.E313.
Effects of the novel gastrointestinal polypeptide PHI with N-terminal histidine, C-terminal isoleucine amide, and 27 amino acids have been studied in isolated perfused rat pancreas. PHI increased the release of insulin, glucagon, and somatostatin. The amounts of these hormones released were strictly dependent on the prevailing glucose concentrations. In the absence of glucose, PHI (1 nmol/liter) stimulated glucagon release. In the presence of 4.4 and 6.7 mmol/liter glucose, the same dose of this peptide stimulated insulin and somatostatin release. In the presence of 16.7 mmol/liter glucose, only insulin secretion was increased by PHI. When arginine was used as a secretagogue, PHI (10 nmol/liter) potentiated secretion of insulin, glucagon, and somatostatin. Thus, PHI may take part in the regulation of the function of the pancreatic A, B, and D cells.
新型胃肠多肽PHI(N端为组氨酸,C端为异亮氨酸酰胺,含27个氨基酸)对离体灌注大鼠胰腺的作用已得到研究。PHI可增加胰岛素、胰高血糖素和生长抑素的释放。这些激素的释放量严格取决于当时的葡萄糖浓度。在无葡萄糖的情况下,PHI(1纳摩尔/升)刺激胰高血糖素释放。在存在4.4和6.7毫摩尔/升葡萄糖的情况下,相同剂量的该肽刺激胰岛素和生长抑素释放。在存在16.7毫摩尔/升葡萄糖的情况下,PHI仅增加胰岛素分泌。当使用精氨酸作为促分泌剂时,PHI(10纳摩尔/升)增强胰岛素、胰高血糖素和生长抑素的分泌。因此,PHI可能参与胰腺A、B和D细胞功能的调节。